GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (LSE:RENE) » Definitions » Long-Term Capital Lease Obligation

ReNeuron Group (LSE:RENE) Long-Term Capital Lease Obligation : £0.19 Mil (As of Sep. 2023)


View and export this data going back to 2005. Start your Free Trial

What is ReNeuron Group Long-Term Capital Lease Obligation?

ReNeuron Group's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was £0.19 Mil.

ReNeuron Group's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 (£0.35 Mil) to Mar. 2023 (£0.27 Mil) and declined from Mar. 2023 (£0.27 Mil) to Sep. 2023 (£0.19 Mil).

ReNeuron Group's annual Long-Term Capital Lease Obligation declined from Mar. 2021 (£0.56 Mil) to Mar. 2022 (£0.42 Mil) and declined from Mar. 2022 (£0.42 Mil) to Mar. 2023 (£0.27 Mil).


ReNeuron Group Long-Term Capital Lease Obligation Historical Data

The historical data trend for ReNeuron Group's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReNeuron Group Long-Term Capital Lease Obligation Chart

ReNeuron Group Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.71 0.56 0.42 0.27

ReNeuron Group Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.42 0.35 0.27 0.19

ReNeuron Group  (LSE:RENE) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

ReNeuron Group Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of ReNeuron Group's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


ReNeuron Group (LSE:RENE) Business Description

Industry
Traded in Other Exchanges
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.